论文部分内容阅读
Objective Cervical cancer is one of the most common causes of mortality to females in the world.At present, paclitaxel (taxol) is the first line drug used to therapy of cervical cancer.However,administration of chemotherapy such as paclitaxel usually results in drug resistance and shows no significant effect on advanced cervical cancer.